drugset / Trial / NCT05943028

Effect of Subanesthetic Dose Esketamine on Propofol-refentanil Closed-loop Targeted Controlled Infusion

NCT05943028

Phase 0 Unknown 48 enrolled bo xu
RandomizedParallel-groupTriple-blindTreatment

Summary

The propofol-refentanil program-controlled closed-loop target-controlled infusion system based on NI guidance has been clinically verified. In the case of clinical use of esketamine, the separation anesthesia properties do not affect the accuracy and safety of closed-loop system guidance. However, whether the specific degree of impact can be quantified, and based on quantitative indicators, this model can be better applied to a wider range of clinical actual conditions and different drug administration backgrounds.

Timeline

Start
2023-07-01
Primary completion
2024-10-01
Completion
2024-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 5 ug/kg Intravenous

Indications

No indication recorded.